GAM
ATOS icon

Gotham Asset Management’s Atossa Therapeutics ATOS Stock Holding History

Gotham Asset Management’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,492
Closed -$141K – 1021
2021
Q2 		$141K Buy
+1,492
New +$79K 0.01% 963

Other funds holding ATOS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Gotham Asset Management's ATOS Position: Q3 2021 in Review

Gotham Asset Management sold out of Atossa Therapeutics (ATOS) in Q3 2021, closing a stake of 1,492 shares — an estimated $141K sold.

Gotham Asset Management first reported a position in ATOS in Q2 2021 and held it in 1 quarter. The position peaked at $141K in Q2 2021. 93 funds tracked by Wall St. Rank hold ATOS as of Q3 2021.

  • Gotham Asset Management reported no remaining Atossa Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Gotham Asset Management sold 1,492 Atossa Therapeutics shares in Q3 2021, an estimated $141K.
  • Gotham Asset Management first reported a position in Atossa Therapeutics in Q2 2021 and held it in 1 quarter.
  • Gotham Asset Management's Atossa Therapeutics position peaked at $141K in Q2 2021.
  • 93 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q3 2021.

Based on Gotham Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.